India, China continue to dominate CRO landscape in Asia Pacific, says Biopectrum-CMR Asia Pacific Annual Survey of CROs
Oct.20, 2012 in
News
(1888PressRelease) Contract and clinical research organizations (CROs) in the Asia Pacific region are increasingly being leverage by the biopharmaceutical industry to counter challenges of recession, patent expiry, rising R&D costs and dwindling productivity.
Comments Off on India, China continue to dominate CRO landscape in Asia Pacific, says Biopectrum-CMR Asia Pacific Annual Survey of CROs
